Erin's Faces Mineral Sunscreen SPF 32 recalled for manufacturing deviations
Erin's Faces Mineral SPF 32 Sunscreen (54 tubes, Lot 410-002) is being recalled due to manufacturing practice deviations. The product was distributed in New Jersey, Florida, and Michigan.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II voluntary recall due to manufacturing practice deviations. No illnesses or injuries have been reported, meeting the criteria for moderate severity as a voluntary precautionary recall without identified consumer harm.
Plain-English summary
KABANA SKIN CARE is recalling Erin's Faces Mineral SPF 32 UVA/UVB Sunscreen, a broad spectrum sunscreen containing 25% zinc oxide, in 3 FL OZ (85 mL) bottles. The recall involves 54 tubes with Lot 410-002.
The firm initiated this voluntary recall due to cGMP (current good manufacturing practice) deviations discovered in the manufacturing process. The affected product was distributed in New Jersey, Florida, and Michigan.
Consumers who have purchased this product should discontinue use and contact the manufacturer or consult with a healthcare provider with questions about this recall.
The recalled product
- Product
- Erin's Faces, Mineral SPF 32, UVA/UVB Sunscreen, Broad Spectrum SPF 32, 25% Zinc Oxide, 3 FL OZ/ 85 mL per bottle, Made in USA for Erin's Faces, Millburn, NO 07041. NDC: 73369-1401-1
- Manufacturer
- KABANA SKIN CARE
- Category
- Drug
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 410-002
Distribution
Distributed in 3 states:
- FL
- MI
- NJ
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27